These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35605512)

  • 1. Association between probable REM sleep behavior disorder and increased dermal alpha-synuclein deposition in Parkinson's disease.
    Doppler K; Mammadova S; Kuzkina A; Reetz K; Michels J; Hermann W; Sommerauer M; Volkmann J; Oertel WH; Janzen A; Sommer C
    Parkinsonism Relat Disord; 2022 Jun; 99():58-61. PubMed ID: 35605512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
    Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
    Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies.
    Poggiolini I; Gupta V; Lawton M; Lee S; El-Turabi A; Querejeta-Coma A; Trenkwalder C; Sixel-Döring F; Foubert-Samier A; Pavy-Le Traon A; Plazzi G; Biscarini F; Montplaisir J; Gagnon JF; Postuma RB; Antelmi E; Meissner WG; Mollenhauer B; Ben-Shlomo Y; Hu MT; Parkkinen L
    Brain; 2022 Apr; 145(2):584-595. PubMed ID: 34894214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligomeric Alpha-Synuclein and STX-1A from Neural-Derived Extracellular Vesicles (NDEVs) as Possible Biomarkers of REM Sleep Behavior Disorder in Parkinson's Disease: A Preliminary Cohort Study.
    Meloni M; Agliardi C; Guerini FR; Saibene FL; Milner AV; Zanzottera M; Bolognesi E; Puligheddu M; Figorilli M; Navarro J; Clerici M
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism.
    Al-Qassabi A; Tsao TS; Racolta A; Kremer T; Cañamero M; Belousov A; Santana MA; Beck RC; Zhang H; Meridew J; Pugh J; Lian F; Robida MD; Ritter M; Czech C; Beach TG; Pestic-Dragovich L; Taylor KI; Zago W; Tang L; Dziadek S; Postuma RB
    Mov Disord; 2021 Apr; 36(4):895-904. PubMed ID: 33232556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-synuclein antibody 5G4 identifies idiopathic REM-sleep behavior disorder in abdominal skin biopsies.
    Tóth Š; Kulcsárová K; Maretta M; Kunová A; Mechírová E; Gdovinová Z; Feketeová E; Ribeiro Ventosa J; Baloghová J; Bekeová M; Christová P; Mrázová S; Muránska S; Zeidan D; Škorvánek M
    Parkinsonism Relat Disord; 2024 Mar; 120():105956. PubMed ID: 38217955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermal Real-Time Quaking-Induced Conversion Is a Sensitive Marker to Confirm Isolated Rapid Eye Movement Sleep Behavior Disorder as an Early α-Synucleinopathy.
    Kuzkina A; Panzer C; Seger A; Schmitt D; Rößle J; Schreglmann SR; Knacke H; Salabasidou E; Kohl A; Sittig E; Barbe M; Berg D; Volkmann J; Sommer C; Oertel WH; Schaeffer E; Sommerauer M; Janzen A; Doppler K
    Mov Disord; 2023 Jun; 38(6):1077-1082. PubMed ID: 36750755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
    Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consistent skin α-synuclein positivity in REM sleep behavior disorder - A two center two-to-four-year follow-up study.
    Doppler K; Antelmi E; Kuzkina A; Donadio V; Incensi A; Plazzi G; Pizza F; Marelli S; Ferini-Strambi L; Tinazzi M; Mayer G; Sittig E; Booij J; Sedghi A; Oertel WH; Volkmann J; Sommer C; Janzen A; Liguori R
    Parkinsonism Relat Disord; 2021 May; 86():108-113. PubMed ID: 33895068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study.
    Knudsen K; Fedorova TD; Hansen AK; Sommerauer M; Otto M; Svendsen KB; Nahimi A; Stokholm MG; Pavese N; Beier CP; Brooks DJ; Borghammer P
    Lancet Neurol; 2018 Jul; 17(7):618-628. PubMed ID: 29866443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. REM sleep behavior disorder and neuropathology in Parkinson's disease.
    Postuma RB; Adler CH; Dugger BN; Hentz JG; Shill HA; Driver-Dunckley E; Sabbagh MN; Jacobson SA; Belden CM; Sue LI; Serrano G; Beach TG
    Mov Disord; 2015 Sep; 30(10):1413-7. PubMed ID: 26265105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological interventions targeting α-synuclein aggregation triggered REM sleep behavior disorder and early development of Parkinson's disease.
    Du L; He X; Fan X; Wei X; Xu L; Liang T; Wang C; Ke Y; Yung WH
    Pharmacol Ther; 2023 Sep; 249():108498. PubMed ID: 37499913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating rapid eye movement sleep without atonia in Parkinson's disease using the rapid eye movement sleep behavior disorder screening questionnaire.
    Bolitho SJ; Naismith SL; Terpening Z; Grunstein RR; Melehan K; Yee BJ; Coeytaux A; Gilat M; Lewis SJ
    Mov Disord; 2014 May; 29(6):736-42. PubMed ID: 24619826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson's disease: a genetic association study.
    Bjørnarå KA; Pihlstrøm L; Dietrichs E; Toft M
    BMC Neurol; 2018 Feb; 18(1):20. PubMed ID: 29466944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study.
    Iranzo A; Fairfoul G; Ayudhaya ACN; Serradell M; Gelpi E; Vilaseca I; Sanchez-Valle R; Gaig C; Santamaria J; Tolosa E; Riha RL; Green AJE
    Lancet Neurol; 2021 Mar; 20(3):203-212. PubMed ID: 33609478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson disease with REM sleep behavior disorder: features, α-synuclein, and inflammation.
    Hu Y; Yu SY; Zuo LJ; Cao CJ; Wang F; Chen ZJ; Du Y; Lian TH; Wang YJ; Chan P; Chen SD; Wang XM; Zhang W
    Neurology; 2015 Mar; 84(9):888-94. PubMed ID: 25663225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body-First Subtype of Parkinson's Disease with Probable REM-Sleep Behavior Disorder Is Associated with Non-Motor Dominant Phenotype.
    Pavelka L; Rauschenberger A; Landoulsi Z; Pachchek S; Marques T; Gomes CPC; Glaab E; May P; Krüger R;
    J Parkinsons Dis; 2022; 12(8):2561-2573. PubMed ID: 36245388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder.
    Stefani A; Iranzo A; Holzknecht E; Perra D; Bongianni M; Gaig C; Heim B; Serradell M; Sacchetto L; Garrido A; Capaldi S; Sánchez-Gómez A; Cecchini MP; Mariotto S; Ferrari S; Fiorini M; Schmutzhard J; Cocchiara P; Vilaseca I; Brozzetti L; Monaco S; Jose Marti M; Seppi K; Tolosa E; Santamaria J; Högl B; Poewe W; Zanusso G;
    Brain; 2021 May; 144(4):1118-1126. PubMed ID: 33855335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid eye movement sleep without atonia may help diagnose Lewy body disease in middle-aged and older patients with somatic symptom disorder.
    Munechika T; Fujishiro H; Okuda M; Iwamoto K; Torii Y; Iritani S; Ozaki N
    Psychogeriatrics; 2017 Jan; 17(1):61-69. PubMed ID: 26757172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probable rapid eye movement sleep behavior disorder, nocturnal disturbances and quality of life in patients with Parkinson's disease: a case-controlled study using the rapid eye movement sleep behavior disorder screening questionnaire.
    Suzuki K; Miyamoto T; Miyamoto M; Watanabe Y; Suzuki S; Tatsumoto M; Iwanami M; Sada T; Kadowaki T; Numao A; Hashimoto K; Sakuta H; Hirata K
    BMC Neurol; 2013 Feb; 13():18. PubMed ID: 23394437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.